Meloxicam 7.5 mg

DRUG4 trials

Sponsors

Boehringer Ingelheim, Alfarabi Colleges, University of Oklahoma

Conditions

DysmenorrheaPainPostoperative Pain, AcuteSkin CancerSymptomatic Irreversible Pulpitis

Phase 2

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

CompletedNCT02183051

Boehringer IngelheimPain

Start: 1998-04-30Updated: 2014-07-08

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

CompletedNCT02183025

Boehringer IngelheimDysmenorrhea

Start: 1998-01-31Updated: 2018-08-31

Phase 4

Meloxicam in Mohs Micrographic Surgery

RecruitingNCT07200544

University of OklahomaPostoperative Pain, Acute, Skin Cancer

Start: 2025-10-15End: 2026-08-02Target: 300Updated: 2025-12-15

Unknown Phase

Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block

CompletedNCT05097768

Alfarabi CollegesSymptomatic Irreversible Pulpitis

Start: 2021-08-15End: 2022-01-27Updated: 2022-02-14